KALA BIO, Inc.
- KALA
- NASDAQ
- Biotechnology
- Nanoparticle Drug Delivery
- Ophthalmology (MPP)
$0.19
Today −1.20%Quote Oct 16, 2026, 08:00 PM UTC
−66.37%over the last month
Max drawdown −68.6%From 1-month high −68.3%3 months −74.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.7M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$18.25
+9510.3% from here
Floor
$0.15
23.1% below price
Where the price sits
11 analysts
Analyst range, low to high
$1.50$35.00
- Price $0.19
- Resistance $0.22
- Consensus $18.25
Analysts' average target sits about 9510% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about KALAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
6